These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 947120)

  • 41. [Somatomedin activity of the serum in the normal child and in hypopituitarism].
    Binet E; Schlumberger A; Chaussain JL; Job JC
    Arch Fr Pediatr; 1974 Apr; 31(4):339-46. PubMed ID: 4368260
    [No Abstract]   [Full Text] [Related]  

  • 42. Constancy of somatomedin response to growth hormone treatment of hypopituitary dwarfism, and lack of correlation with growth rate.
    Rosenfeld RG; Kemp SF; Hintz RL
    J Clin Endocrinol Metab; 1981 Sep; 53(3):611-7. PubMed ID: 7021582
    [No Abstract]   [Full Text] [Related]  

  • 43. Actions of growth hormone, prolactin and thyroxine on serum somatomedin-like activity and growth in hypopituitary dwarf mice.
    Holder AT; Wallis M
    J Endocrinol; 1977 Aug; 74(2):223-9. PubMed ID: 894170
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunoreactive somatomedin A in human serum.
    Hall K; Brandt J; Enberg G; Fryklund L
    J Clin Endocrinol Metab; 1979 Feb; 48(2):271-8. PubMed ID: 218985
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Somatomedin levels in cerebrospinal fluid from adults with pituitary disorders.
    Bäckström M; Hall K; Sara V
    Acta Endocrinol (Copenh); 1984 Oct; 107(2):171-8. PubMed ID: 6388207
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum somatomedin levels in adults with chronic renal failure: the importance of measuring insulin-like growth factor I (IGF-I) and IGF-II in acid-chromatographed uremic serum.
    Powell DR; Rosenfeld RG; Baker BK; Liu F; Hintz RL
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1186-92. PubMed ID: 3760118
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human somatomedin. Determination, occurrence, biological activity and purification.
    Hall K
    Acta Endocrinol Suppl (Copenh); 1972; 163():1052. PubMed ID: 4538721
    [No Abstract]   [Full Text] [Related]  

  • 48. [A comparison of radioimmunoassay and radioreceptor assay of serum growth hormone in children with growth disorders (author's transl)].
    Maesaka H; Suwa S
    Nihon Naibunpi Gakkai Zasshi; 1980 Feb; 56(2):164-70. PubMed ID: 6989653
    [No Abstract]   [Full Text] [Related]  

  • 49. Radioreceptor assay of insulin-like peptides in human plasma: growth hormone dependence and correlation with sulfation activity by two bioassays.
    Guyda HJ; Corvol MT; Rappaport R; Posner BI
    J Clin Endocrinol Metab; 1979 May; 48(5):739-47. PubMed ID: 429519
    [No Abstract]   [Full Text] [Related]  

  • 50. Somatomedin A and B in serum from neonates, their mothers and cord blood.
    Svan H; Hall K; Ritzén M; Takano K; Skottner A
    Acta Endocrinol (Copenh); 1977 Jul; 85(3):636-43. PubMed ID: 577342
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of bromocriptine on serum hormones in acromegaly.
    Carlson HE; Levin SR; Braunstein GD; Spencer EM; Wilson SE; Hershman JM
    Horm Res; 1984; 19(3):142-52. PubMed ID: 6425186
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum somatomedin A in chronic renal failure.
    Takano K; Hall K; Kastrup KW; Hizuka N; Shizume K; Kawai K; Akimoto M; Takuma T; Sugino N
    J Clin Endocrinol Metab; 1979 Mar; 48(3):371-6. PubMed ID: 218989
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum somatomedin-C in hypopituitarism and in other disorders of growth.
    D'Ercole AJ; Underwood LE; Van Wyk JJ
    J Pediatr; 1977 Mar; 90(3):375-81. PubMed ID: 839329
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum concentrations of somatomedins and growth hormone in relation to bone metabolism in acromegaly and thyroid dysfunction.
    Bijlsma JW; Duursma SA
    Clin Exp Rheumatol; 1986; 4(2):105-10. PubMed ID: 3731567
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Somatomedin following administration of growth hormone in pituitary dwarfism].
    Marek J; Kopecký A; Schüllerová M; Schreiberová O
    Cesk Pediatr; 1978 Oct; 33(10):582-6. PubMed ID: 729059
    [No Abstract]   [Full Text] [Related]  

  • 56. [Clinical use in the radioimmunologic determination of plasmatic TSH].
    Faggiano M; Lombardi G; Carella C; Minozzi M
    Quad Sclavo Diagn; 1975 Jun; 11(2):359-71. PubMed ID: 1223942
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Somatomedin and growth hormone in psychosocial dwarfism.
    Saenger P; Levine LS; Wiedemann E; Schwartz E; Korth-Schutz S; Pareira J; Heinig B; New MI
    Padiatr Padol Suppl; 1977; (5):1-12. PubMed ID: 917570
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Somatomedins--a review. 2. Age and nutrition dependence, somatomedin concentration in endocrine and non-endocrine diseases].
    Jahreis G; Hesse V
    Kinderarztl Prax; 1983 Sep; 51(9):403-12. PubMed ID: 6656098
    [No Abstract]   [Full Text] [Related]  

  • 59. Non-suppressible insulin-like activity and sulphaton activity in serum extracts of normal subjects, acromegalics and pituitary dwarfs.
    Schlumpf U; Heimann R; Zapf J; Froesch ER
    Acta Endocrinol (Copenh); 1976 Jan; 81(1):28-42. PubMed ID: 946140
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The somatomedins: insulin-like growth factors.
    Baxter RC
    Adv Clin Chem; 1986; 25():49-115. PubMed ID: 2424282
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.